Florence today announced its membership in the Avoca Quality Consortium® (AQC) to drive technology adoption and standardization in order to reduce drug costs and development time.

Research application segment of medical devices vigilance market is expected to register 8.5% CAGR from 2019 to 2025 owing to growing investments by public sector.